NCT01581320

Phase III Clinical Trial of DP-R206 and Bonvia In Postmenopausal Women With Osteoporosis

A Multicenter, Randomized, Double-blind, Active-controlled, Phase III Clinical Trial to Evaluate the Efficacy and Safety of DP-R206 and Bonviva for the Improvement of Vitamin D in Postmenopausal Women With Osteoporosis

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 201 (actual)
• Sponsor: Alvogen Korea · Industry
• Sex: Female
• Age: 40 Years
• Healthy volunteers: Not accepted

Summary

A multicenter, randomized, double-blind, active-controlled, phase III clinical trial to evaluate the efficacy and safety of Dp-R206 and Bonviva for 16 weeks once a month on the improvement of vitamin D in postmenopausal women with osteoporosis.

Conditions

• Postmenopausal Women With Osteoporosis

Interventions

Type	Name	Description
DRUG	Test group	Once a month, administration of DP-R206 \& placebo for 16 weeks
DRUG	Reference group	Once a month, administration of Bonviva \& placebo for 16 weeks

Timeline

• Start date: 2011-12-01
• Primary completion: 2012-09-01
• Completion: 2012-09-01
• First posted: 2012-04-20
• Last updated: 2016-11-01

Locations

1 site across 1 country: South Korea